These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15725062)

  • 1. Fondaparinux.
    Tan KT; Lip GY
    Curr Pharm Des; 2005; 11(4):415-9. PubMed ID: 15725062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor X inhibitors.
    Tan KT; Makin A; Lip GY
    Expert Opin Investig Drugs; 2003 May; 12(5):799-804. PubMed ID: 12720491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety of fondaparinux for the prevention and treatment of venous thromboembolism.
    Turpie AG
    Expert Opin Drug Saf; 2005 Jul; 4(4):707-21. PubMed ID: 16011449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.
    Tran AH; Lee G
    Ann Pharmacother; 2003 Nov; 37(11):1632-43. PubMed ID: 14565815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
    Turpie AG
    Int J Clin Pract; 2004 May; 58(5):483-93. PubMed ID: 15206506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging options for thromboprophylaxis after orthopedic surgery: a review of clinical data.
    Lobo BL
    Pharmacotherapy; 2004 Jul; 24(7 Pt 2):66S-72S. PubMed ID: 15317401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery.
    Bergqvist D
    Vasc Health Risk Manag; 2006; 2(4):365-70. PubMed ID: 17323590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on fondaparinux: role in management of thromboembolic and acute coronary events.
    Sharma T; Mehta P; Gajra A
    Cardiovasc Hematol Agents Med Chem; 2010 Apr; 8(2):96-103. PubMed ID: 20184552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PK evaluation of fondaparinux sodium for the treatment of thrombosis.
    Delavenne X; Frappé P; Zufferey P; Mismetti P; Laporte S; Bertoletti L
    Expert Opin Drug Metab Toxicol; 2014 Feb; 10(2):269-77. PubMed ID: 24359588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fondaparinux: pharmacology and clinical experience in cardiovascular medicine.
    Toschi V; Lettino M
    Mini Rev Med Chem; 2007 Apr; 7(4):383-7. PubMed ID: 17430224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium.
    Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P
    Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fondaparinux for the prevention or treatment of venous thromboembolism related to lower limb trauma: evidence today.
    Kanakaris NK; Nikolaou VS; Tosounidis T; Giannoudis PV
    Curr Vasc Pharmacol; 2008 Apr; 6(2):134-42. PubMed ID: 18393915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.
    Turpie AG
    Expert Opin Pharmacother; 2004 Jun; 5(6):1373-84. PubMed ID: 15163281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fondaparinux for thrombosis prevention after orthopaedic surgery: a revolution?].
    Monreal M
    Med Clin (Barc); 2003 May; 120(20):775-6. PubMed ID: 12797930
    [No Abstract]   [Full Text] [Related]  

  • 15. Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery.
    Reynolds NA; Perry CM; Scott LJ
    Drugs; 2004; 64(14):1575-96. PubMed ID: 15233593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fondaparinux, the first selective factor Xa inhibitor.
    Turpie AG; Eriksson BI; Lassen MR; Bauer KA
    Curr Opin Hematol; 2003 Sep; 10(5):327-32. PubMed ID: 12913785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism.
    Robinson DM; Wellington K
    Am J Cardiovasc Drugs; 2005; 5(5):335-46. PubMed ID: 16156690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAfety of Fondaparinux in transoesophageal echocardiography-guided Electric cardioversion of Atrial Fibrillation (SAFE-AF) study: a pilot study.
    Cohen A; Stellbrink C; Le Heuzey JY; Faber T; Aliot E; Banik N; Kropff S; Omran H;
    Arch Cardiovasc Dis; 2015 Feb; 108(2):122-31. PubMed ID: 25684570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance?
    Lowe GD; Sandercock PA; Rosendaal FR
    Lancet; 2003 Aug; 362(9383):504-5. PubMed ID: 12932379
    [No Abstract]   [Full Text] [Related]  

  • 20. A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery.
    Sullivan SD; Davidson BL; Kahn SR; Muntz JE; Oster G; Raskob G
    Pharmacoeconomics; 2004; 22(9):605-20. PubMed ID: 15209529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.